chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: HPV9
Symptoms: Delivery, Exposure during pregnancy
Clinical narrative: This spontaneous retrospective pregnancy report was received from a physician concerning to a female patient (age not reported). No concomitant medications, medical history nor concurrent conditions were reported. On an unknown date, while the patient was 8 months pregnant, she was vaccinated with a dose of GARDASIL 9 (Site, route, dose, lot number and expiration date not reported) for prophylaxis. The last menstrual period and estimated delivery date were not reported. On an unknown date, the patient delivered a baby (gender and fetal outcome were not reported).
Age: 1.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: No adverse event, Wrong product administered
Clinical narrative: This spontaneous report was received from a medical assistant referring to a 13 month old male patient. The patient had no medical history, concurrent conditions nor concomitant therapies. On 15-NOV-2018, the patient was vaccinated with a dose of ZOSTAVAX (dose was not provided) per subcutaneous route lot # N025570; instead of the scheduled VARIVAX (for varicella vaccination) because ZOSTAVAX was mistakenly placed in the VARIVAX container. No adverse effect was reported.
Sex: U
Vaccine: RV5
Symptoms: Immediate post-injection reaction, Infantile spitting up, Oral administration complication
Clinical narrative: This spontaneous report was received from a nurse, referring to a 2 month old patient of an unknown gender. The patient's historical conditions, concurrent conditions, concomitant therapies, historical drugs or allergies were unknown. On 28-NOV-2018, the patient was vaccinated with ROTATEQ, orally (strength, dose number, frequency, lot number and expiration date were not provided) for prevention of rotavirus. On the same date, immediately after vaccination the patient "spit it all up" (infantile spitting up and underdose). The outcome of infantile spitting up was reported as recovered/resolved. The patient did not receive any treatment for the event. No product quality complaint was reported. The causal relationship between infantile spitting up and vaccination with ROTATEQ was unknown.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received on 27-NOV-2018 regarding a case in litigation from a lawyer concerning a female patient of unknown age. There was no information provided regarding the patient's concurrent conditions, medical history or concomitant medications. The patient's healthcare provider, recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. In 2010, a pharmacist at a pharmacy administered the ZOSTAVAX (lot number, expiration, dose and route unknown) to the patient. In 2015, the patient was treated by the patient's healthcare provider at a physician's office for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX, and suffered serious physical, emotional and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events is unknown. The causality of the events is related. Additional information has been requested.
Age: 1.0
Sex: U
Vaccine: VARZOS
Symptoms: No adverse event, Wrong product administered
Clinical narrative: This spontaneous report was received from a medical assistant, and refers to a 12 month old patient of unknown gender. Information about the patient's medical history, concurrent conditions, concomitant medications and drug reactions/allergies was not provided. On 15-NOV-2018, the patient was inadvertently vaccinated with a dose of ZOSTAVAX (lot # N025570 with an expiration date in 13-DEC-2018), for prophylaxis, instead of a dose of VARIVAX. No adverse effect reported.
Age: 1.0
Sex: M
Vaccine: MMRV, VARCEL
Symptoms: Extra dose administered, No adverse event
Clinical narrative: This spontaneous report was received from a registered nurse and refers to a 12 month old male patient. The patient's concurrent conditions, medical history and concomitant medications were not reported. On 28-NOV-2018, the patient was vaccinated with PROQUAD lot # N035177, expiration date 09-JUL-2019 (route, dose and frequency were not reported) for prophylaxis. On the same date, the patient was vaccinated with VARIVAX lot # R018777, expiration date 01-JUL-2020 (route, dose and frequency were not reported) for prophylaxis. No adverse effects reported.
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age.  No information was provided regarding concurrent conditions, medical history, or concomitant medications. On or about 2013, a healthcare provider administered ZOSTAVAX to the patient to obtain permanent prevention and protection against shingles and zoster-related injuries and conditions (dose, route, and lot number not provided). On or about 26-NOV-2016, the patient was treated by a healthcare professional for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with ZOSTAVAX, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of ZOSTAVAX, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was not recovered. Causality assessment was related. Additional information has been requested.
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider, a pharmacist, recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On an unknown date in 2016, a pharmacist administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). On an unknown date later in 2016, the patient was treated by a healthcare provider for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization (dates unknown), physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider, a pharmacist, recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On an unknown date in 2013, a pharmacist at a pharmacy administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). On an unknown date in 2015, the patient was treated by a healthcare provider at a hospital for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization (dates unknown), physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about January 2011, a pharmacist at a pharmacy administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). On or about January 2013, the patient was treated by a physician for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization (dates unknown), physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received on 27-NOV-2018 regarding a case in litigation from a lawyer concerning a female patient of unknown age. There was no information provided regarding the patient's concurrent conditions, medical history or concomitant medications. The patient's healthcare provider, recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 2010, a healthcare provider at a physician's office administered the ZOSTAVAX (lot number, expiration, dose and route unknown) to the patient. On or about 04-MAR-2014, the patient was treated by a physician for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX, and suffered serious physical, emotional and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events is unknown. The causality of the events is related. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received on 27-NOV-2018 regarding a case in litigation from a lawyer concerning a female patient of unknown age. There was no information provided regarding the patient's concurrent conditions, medical history or concomitant medications. The patient's healthcare provider, recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 11-DEC-2014, a licensed practical nurse at a medical center administered the ZOSTAVAX (lot number, expiration, dose and route unknown) to the patient. On or about 24-AUG-2016, the patient was treated by a physician at a medical center for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX, and suffered serious physical, emotional and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events is unknown. The causality of the events is related. Additional information has been requested.
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Information has been received on 27-NOV-2018 regarding a case in litigation from a lawyer concerning a male patient of unknown age. There was no information provided regarding the patient's concurrent conditions, medical history or concomitant medications. The patient's healthcare provider, recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 10-JUL-2015, a pharmacist at a pharmacy administered the ZOSTAVAX (lot number, expiration, dose and route unknown) to the patient. In 2015, the patient was treated by the patient's healthcare provider at a hospital for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX, and suffered serious physical, emotional and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events is unknown. The causality of the events is related. Additional information has been requested.
Sex: U
Vaccine: HEPA
Symptoms: No adverse event, Product storage error
Clinical narrative: This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 29-NOV-2018, the patient was vaccinated with an improperly stored dose of VAQTA with lot # R017644 with expiration date on 09-AUG-2019 for prophylaxis (dose and route of administration were not reported). However, no adverse effects were reported. The administered dose of the vaccine experienced an unspecified temperature excursion on an unknown date for an unspecified time. This report was not due to a digital data logger. No product quality complaint was involved.
Sex: U
Vaccine: PPV
Symptoms: No adverse event, Product storage error
Clinical narrative: This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies, concurrent conditions and concomitant medications were not reported. On 29-NOV-2018, the patient was vaccinated with improperly stored PNEUMOVAX 23 lot # R022754 with expiration date 12-JUL-2020, for prophylaxis (dose, route of administration and anatomical location were not reported). No adverse effects were reported. The temperature at which the vaccine was exposed and the time frame were not provided. No previous temperature excursion was reported.
Sex: F
Vaccine: HEPA
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: This spontaneous report was received from a health professional referring to a 16 year old female patient. On 28-NOV-2018, the patient was vaccinated with VAQTA, intramuscular for prophylaxis. On an unknown date, the patient experienced inappropriate schedule of product administration and no adverse event.
Age: 75.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Insomnia, Pain, Pruritus
Clinical narrative: Information has been received from a 75 year old female with high cholesterol, thyroid problems, allergy to MINOCIN and a history of knee replacement who in November 2007, was vaccinated with zoster vaccine live (Oka/Merck). Concomitant therapy included SYNTHROID. The patient had shingles twice since the vaccination. Once in January 2008 on her right side and again on 09-JUL-2009 the patient experienced shingles again beginning on her left side. She had extreme itching and pain that prevents her from sleeping. She had been prescribed prednisone, hydrocodone and a sleeping pill for the current shingles. Unspecified medical attention was sought. Information has been received on 27-NOV-2018 regarding a case in litigation from a lawyer concerning a female patient of unknown age. There was no information regarding the patient's concurrent conditions, medical history or concomitant medications. The patient's healthcare provider, recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 17-OCT-2007 (previously reported November 2007), at pharmacist administered the ZOSTAVAX (lot number, expiration, dose and route unknown) to the patient. In 2008, the patient was treated by the patient's healthcare providers for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX, and suffered serious physical, emotional and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered not recovered. The causality of the events is related. Additional information has been requested.
Age: 1.25
Sex: F
Vaccine: DTAP, FLU4, PNC13
Symptoms: Febrile convulsion
Clinical narrative: Patient sustained febrile seizure one day after receiving vaccines as listed above. Patient did not have any other illnesses present at this time.
Age: 0.0
Sex: F
Vaccine: HEP
Symptoms: Apnoea
Clinical narrative: Apnea, experienced 3 times while on the monitor.
Age: 43.0
Sex: F
Vaccine: FLUC4
Symptoms: Pain in extremity
Clinical narrative: Patient complaint: left arm pain from shoulder to elbow beginning 11/11/18 after flu shot.
Age: 55.0
Sex: M
Vaccine: VARZOS
Symptoms: Abdominal discomfort, Chest pain, Chills, Fatigue, Headache
Clinical narrative: Within 1 day: pain, redness, and swelling at the injection site, muscle pain, tiredness, headache, shivering, fever, and upset stomach. Still 5 weeks after 2nd shot, lump at injection site, very sore, pain travels into chest and up neck to temple causing headaches, sore to move arm, worse at night and effects getting to sleep.
Age: 55.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site mass, Injection site pain, Injection site swelling, Insomnia
Clinical narrative: Within 1 day: pain, redness, and swelling at the injection site, muscle pain, tiredness, headache, shivering, fever, and upset stomach. Still 5 weeks after 2nd shot, lump at injection site, very sore, pain travels into chest and up neck to temple causing headaches, sore to move arm, worse at night and effects getting to sleep.
Age: 55.0
Sex: M
Vaccine: VARZOS
Symptoms: Myalgia, Neck pain, Pain, Pyrexia
Clinical narrative: Within 1 day: pain, redness, and swelling at the injection site, muscle pain, tiredness, headache, shivering, fever, and upset stomach. Still 5 weeks after 2nd shot, lump at injection site, very sore, pain travels into chest and up neck to temple causing headaches, sore to move arm, worse at night and effects getting to sleep.
Age: 5.0
Sex: M
Vaccine: TDAP
Symptoms: No adverse event, Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: Patient was intended to get the Infuenza vaccination and nurse gave an ADACEL. The patients age (5) is less than the recommended age to receive an ADACEL injection. Pt did leave the facility before the error was noticed. The physician was notified. The patient's parent was notified and they returned to clinic and received the Influenza vaccine. No adverse reaction was noted. No adverse reaction has been reported to date.
Age: 16.0
Sex: F
Vaccine: HPV9
Symptoms: Hypoaesthesia
Clinical narrative: Left arm with numbness/loss of feeling. No weakness or pain. Resolved after 1 week.
Age: 1.25
Sex: F
Vaccine: DTAPIPVHIB, PNC13, VARCEL
Symptoms: Gait inability, Injection site reaction, Weight bearing difficulty
Clinical narrative: Child was unable to walk/bear weight on left leg from the time she woke up the day after vaccination (6 am) until 4 pm.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Asthenia, Chills, Headache, Injection site erythema, Myalgia
Clinical narrative: H/A, Myalgia, Chills, Weakness, Redness at injection site that spread up arm, Nasal congestion.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Nasal congestion
Clinical narrative: H/A, Myalgia, Chills, Weakness, Redness at injection site that spread up arm, Nasal congestion.
Age: 67.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Influenza like illness, Swelling
Clinical narrative: Pt stated she had redness and swelling as well as flu like symptoms- had Dr. visit-  pt is currenty doing better and "back to normal" as of Monday 12/3/18.
Age: 80.0
Sex: F
Vaccine: PPV
Symptoms: Breast swelling, Erythema, Hypersensitivity, Injection site erythema, Injection site swelling
Clinical narrative: Redness, swelling from elbow to shoulder, and one inch over left breast.
Age: 69.0
Sex: M
Vaccine: UNK
Symptoms: Dizziness, Myalgia
Clinical narrative: Muscle pain, extreme dizziness.
Sex: M
Vaccine: PPV
Symptoms: Injected limb mobility decreased, Pain, Pain in extremity
Clinical narrative: This spontaneous report was received from  the patient's mother referring to her son, of unknown age. The patient's medical history, concurrent conditions and concomitant therapies were not provided. On an unknown date, the patient was vaccinated with a dose of PNEUMOVAX 23 0.5 milliliter (route, lot# and expiration date were not provided) for prophylaxis. On an unknown date "within 4 months" after the first dose,  the patient received a second dose of PNEUMOVAX 23 0.5 milliliter (route, lot# and expiration date were not provided) "to be sure that it would be effective." The patient's mother stated that at the time of the report (reported as "now"), the patient was having difficulty moving the leg that he was given the injection in (movement disorder), and that same leg "hurts whenever he moves (pain in extremity). At the time of the report, the outcome of pain in extremity, and movement disorder was unknown. The reporter did not assess the causal relationship between pain in extremity and movement disorder, with PNEUMOVAX 23.
Sex: U
Vaccine: RV5
Symptoms: No adverse event, Product storage error
Clinical narrative: This spontaneous report was received from a nurse and refers to an unspecified, multiple patients of an unknown age and gender. The patients' pertinent medical history, concomitant medications and drug reaction or allergies were not reported. On an unspecified dates, the patients were vaccinated with improperly stored doses of ROTATEQ lot # R013288, expiration date 01-DEC-2019 (exact strength, doses, frequency and route of administration were not reported) administered for prophylaxis. The doses of ROTATEQ were stored at the temperature of 32 degrees Fahrenheit to 35 degrees Fahrenheit for 48 hours. There were no previous temperature excursions reported. The call was because of data logger. No adverse effects were reported. The outcome of product storage error and no adverse event was unknown.
Age: 52.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Injection site erythema, Injection site swelling, Pain in extremity
Clinical narrative: Joint pain in knees. After about 3 hours took 800mg of Ibuprofen and pain subsided. Arm pain, redness, and swelling at injection site. Arm pain began 12/01/2018 (within 1 day), redness and swelling noticed 12/02/2018 (day 2). All continue as of reporting 12/03/2018.
Age: 1.0
Sex: F
Vaccine: MMR
Symptoms: Full blood count, Immune thrombocytopenic purpura, Prothrombin time
Clinical narrative: Pt was hospitalized with ITP 2.5 weeks post immunization. Symptoms started 2 weeks after immunization
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Dizziness, Influenza like illness, Pyrexia
Clinical narrative: Flu- type symptoms, fever, chills, dizziness.
Age: 47.0
Sex: F
Vaccine: FLU4, PPV
Symptoms: Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Patient reports that she developed tenderness and warmth and mild swelling at the site of injection. Patient denied any other symptoms and was advised to monitor for worsening symptoms and seek medical assistance if symptoms did not improved or worsened. Patient called in at the end of the day when the clinic was closing and she was not seen in the clinic.
Age: 54.0
Sex: F
Vaccine: FLU4
Symptoms: Musculoskeletal pain, Nuclear magnetic resonance imaging
Clinical narrative: Shoulder pain began 6 hours after vaccination, ibuprofen helped in the beginning then it did not.  Steroid injections and Physical Therapy performed. Next surgery to reduce inflammation.
Age: 6.0
Sex: M
Vaccine: FLU4
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Diffuse swelling, redness, and itching of left shoulder and upper arm progressed from onset to 2nd day of reaction when evaluated by MD. Prescribed diphenhydramine, cool packs, elevate arm. Allergist referral. No enhanced redness, tenderness, or swelling at injection site.
Age: 64.0
Sex: M
Vaccine: VARZOS
Symptoms: Dehydration, Hyperhidrosis, Pain
Clinical narrative: Pt reports he woke the next morning feeling extremely dry and dehydrated "as though I had had a fever". Later in the day he thinks he took ibuprofen or ALEVE for body aches. Then around 5 AM on 12/2/18 he woke with drenched sheets - he got up and toweled off, then returned to bed for another hour or two.
Age: 45.0
Sex: F
Vaccine: FLU4
Symptoms: Immediate post-injection reaction, Injected limb mobility decreased, Injection site pain
Clinical narrative: Pt with immediate pain with injection. Continues with shoulder pain and limited range of motion. Seen by primary care.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Hyperhidrosis, Pain
Clinical narrative: Awoke 12/1/18 feeling "sore - almost flu-like". Took ibuprofen twice that day and rested all day. Her last dose was around 8 pm. Then woke around 1 or 2 AM drenched in sweat - head, neck, and upper back.
Age: 47.0
Sex: F
Vaccine: FLUR3
Symptoms: Acoustic stimulation tests, Dizziness, Fatigue, Headache, Hypoacusis
Clinical narrative: Day 2 after vaccine administered: Severe tinnitus/ringing/humming in Right ear/hearing interference along with high pitched tinnitus in both ears/back of head. Dizziness/vertigo - Moderate to severe. Exhaustion/fatigue, muscle weakness. Continued tinnitus in Right ear through mid-August 2018. Exhaustion/fatigue, muscle weakness continued through September 2018. High-pitched tinnitus in both ears/back of head continues. Right ear tinnitus continues intermittently. Visited primary doctor 2x, referred to ENT and for MRI (6.6.2018). Prescribed medication/meclizine for dizziness (no improvement with medication and tests were inconclusive/did not show anything). Tinnitus and headaches continued. Visited Occupational Therapist (7.27.18 and 8.3.18). Cranial sacral work was preformed, after which (approx. early to mid-August) right-ear tinnitus reduced (continue intermittently) and headaches ceased. Some high pitched double-ear/back of head tinnitus continues and right-ear tinnitus continues intermittently. Reluctant to get 2018 flu vaccine due to my experience with the adverse reaction from the 2017 flu vaccine. A doctor at a clinic I recently visited recommended that I report the adverse reaction.
Age: 47.0
Sex: F
Vaccine: FLUR3
Symptoms: Laboratory test, Muscular weakness, Nuclear magnetic resonance imaging, Tinnitus, Vertigo
Clinical narrative: Day 2 after vaccine administered: Severe tinnitus/ringing/humming in Right ear/hearing interference along with high pitched tinnitus in both ears/back of head. Dizziness/vertigo - Moderate to severe. Exhaustion/fatigue, muscle weakness. Continued tinnitus in Right ear through mid-August 2018. Exhaustion/fatigue, muscle weakness continued through September 2018. High-pitched tinnitus in both ears/back of head continues. Right ear tinnitus continues intermittently. Visited primary doctor 2x, referred to ENT and for MRI (6.6.2018). Prescribed medication/meclizine for dizziness (no improvement with medication and tests were inconclusive/did not show anything). Tinnitus and headaches continued. Visited Occupational Therapist (7.27.18 and 8.3.18). Cranial sacral work was preformed, after which (approx. early to mid-August) right-ear tinnitus reduced (continue intermittently) and headaches ceased. Some high pitched double-ear/back of head tinnitus continues and right-ear tinnitus continues intermittently. Reluctant to get 2018 flu vaccine due to my experience with the adverse reaction from the 2017 flu vaccine. A doctor at a clinic I recently visited recommended that I report the adverse reaction.
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Computerised tomogram head, Facial paralysis, Nuclear magnetic resonance imaging brain
Clinical narrative: On November 12th I went to the Emergency Room as I thought I was having a stroke. Half of my face was paralyzed. I was given two CT-scans of the brain and an MRI of the brain before they made the diagnosis of Bell's Palsy.
Age: 16.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Bursitis, Injection site nodule, Injection site pain, Injection site swelling, Loss of personal independence in daily activities
Clinical narrative: Mother states daughter's left shoulder has been sore since the day she was vaccinated. States later that day a knot and swelling developed. States no redness. States daughter has been unable to teach yoga due to the pain. Took daughter to a physical therapist and was told is likely bursitis and gave her some exercises to do at home. Therapist told her the needle may have went too deep in the muscle. Mother states pediatrician told her he can't do anything for it and instructed her to take her to an orthopedic doctor. Mother states can't afford the $200 just to walk in the door- does not have insurance. Mother states pain and "fluid" continues. Mother brought daughter into health department on 11/30/18 and nurse noted that both shoulders were normal and same size, but daughter did have pain with palpation of left shoulder area. Mother called health department today asking for possible resources to help pay for orthopedic care.
Age: 25.0
Sex: F
Vaccine: HPV9
Symptoms: Musculoskeletal pain, Neck pain
Clinical narrative: Pt reports left scapular and neck pain started after injection.
Age: 24.0
Sex: M
Vaccine: FLU4
Symptoms: Hypoaesthesia
Clinical narrative: Patient said he experience numbness on the left side of his body for 20 minutes after the  administration of the flu vaccine. Patient claimed he recovered after 20 minutes.
Age: 19.0
Sex: F
Vaccine: HEPA
Symptoms: Asthenia, Dizziness, Dyspnoea, Exposure during pregnancy, Nausea
Clinical narrative: Client states 4 months pregnant. Complained of lightheadedness, dizziness, weakness and nausea following injection. At one point complained of having a little trouble breathing. Client released following rest and monitoring of vital signs.
Age: 32.0
Sex: F
Vaccine: FLU4
Symptoms: Enlarged uvula, Eye swelling, Pruritus, Skin reaction, Swelling face
Clinical narrative: Employee given FLULAVAL vaccine at 3p. 430p EE started to get itchy, red, hives throughout body, puffy face, eyes. Uvula edema. Seen in ED. Tx with SOLUMEDROL, BENADRYL and fluids. Given prescription for Predisone 40mg po X 4 days. BENADRYL 25mg po every 6hrs X 2 days. EE did not start prescriptions until after seen in EOHS next morning d/t fear of any affects while breastfeeding. EE started on Predisone 11/30 early afternoon. Hives and itching resolved 12/1. Residual puffy eyes on 12/3.
Age: 32.0
Sex: F
Vaccine: FLU4
Symptoms: Urticaria
Clinical narrative: Employee given FLULAVAL vaccine at 3p. 430p EE started to get itchy, red, hives throughout body, puffy face, eyes. Uvula edema. Seen in ED. Tx with SOLUMEDROL, BENADRYL and fluids. Given prescription for Predisone 40mg po X 4 days. BENADRYL 25mg po every 6hrs X 2 days. EE did not start prescriptions until after seen in EOHS next morning d/t fear of any affects while breastfeeding. EE started on Predisone 11/30 early afternoon. Hives and itching resolved 12/1. Residual puffy eyes on 12/3.
Age: 66.0
Sex: F
Vaccine: PPV
Symptoms: Joint range of motion decreased, Musculoskeletal pain, Pain in extremity
Clinical narrative: Severe shoulder pain and upper arm pain for 36 hours. Moderated pain continued for 4 more  days. Range of motion of shoulder and arm were limited for 5 days.
Age: 35.0
Sex: F
Vaccine: FLU4
Symptoms: Electromyogram normal, Insomnia, Pain, Pain in extremity, Paraesthesia
Clinical narrative: Pain throughout whole right arm with tingling in forearm to fingers throbbing pain. Unable to sleep.
Age: 67.0
Sex: F
Vaccine: PPV, PPV
Symptoms: Erythema, Pain, Peripheral swelling, Skin tightness, Skin warm
Clinical narrative: Swelling, redness, warmth on opposite side of injection arm. Spread down arm over the course of 2 days. Not itching, but tight skin (swelling) and radiating warmth, with significant pain upon movement.
Age: 67.0
Sex: F
Vaccine: PPV, PPV
Symptoms: Cellulitis, Erythema, Headache, Induration, Injection site erythema
Clinical narrative: Swelling, redness, warmth on opposite side of injection arm. Spread down arm over the course of 2 days. Not itching, but tight skin (swelling) and radiating warmth, with significant pain upon movement.
Age: 67.0
Sex: F
Vaccine: PPV, PPV
Symptoms: Injection site pain, Loss of personal independence in daily activities, Malaise, Nausea, Pain
Clinical narrative: Swelling, redness, warmth on opposite side of injection arm. Spread down arm over the course of 2 days. Not itching, but tight skin (swelling) and radiating warmth, with significant pain upon movement.
Age: 67.0
Sex: F
Vaccine: PPV, PPV
Symptoms: Peripheral swelling
Clinical narrative: Swelling, redness, warmth on opposite side of injection arm. Spread down arm over the course of 2 days. Not itching, but tight skin (swelling) and radiating warmth, with significant pain upon movement.
Age: 22.0
Sex: F
Vaccine: HPV9, HPV9
Symptoms: Exposure during pregnancy, No adverse event
Clinical narrative: No adverse event occurred with the patient, however, she was pregnant at the time and the pregnancy was not yet known to her or the provider.
Age: 22.0
Sex: F
Vaccine: HPV9, HPV9
Symptoms: Exposure during pregnancy
Clinical narrative: No adverse event occurred with the patient, however, she was pregnant at the time and the pregnancy was not yet known to her or the provider.
Age: 72.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injection site erythema, Injection site rash, Injection site warmth
Clinical narrative: Right bicep has redness/rash/warm to touch. Confined to arm of right bicep. No redness noted at site of injection (only atop bicep). Patient is icing the area and applying hydrocortisone 1%.
Age: 0.58
Sex: F
Vaccine: FLU4
Symptoms: Pyrexia, Rash
Clinical narrative: High fever 103.5 (Saturday 2:00 AM). Rash face, neck, buttock, legs (12/2/18 9:00 PM). Given BENADRYL (12/2/18 - 9:00 PM). Ibuprofen Saturday - at Urgent Care.
Age: 40.0
Sex: F
Vaccine: TDAP
Symptoms: Blood thyroid stimulating hormone normal, Burning sensation, Decreased appetite, Differential white blood cell count normal, Electrocardiogram normal
Clinical narrative: Approximately 8 hours after vaccination reports ipsilateral tinnitus and burning sensation in left arm and left food. Has occurred episodically over the last 4 weeks. Also notes new onset fatigue, malaise, decreased appetite. Trial of prednisone with no improvement. Unclear if vaccination is related.
Age: 40.0
Sex: F
Vaccine: TDAP
Symptoms: Fatigue, Full blood count normal, Inflammatory marker decreased, Malaise, Metabolic function test normal
Clinical narrative: Approximately 8 hours after vaccination reports ipsilateral tinnitus and burning sensation in left arm and left food. Has occurred episodically over the last 4 weeks. Also notes new onset fatigue, malaise, decreased appetite. Trial of prednisone with no improvement. Unclear if vaccination is related.
Age: 40.0
Sex: F
Vaccine: TDAP
Symptoms: Thyroxine normal, Tinnitus, Tri-iodothyronine normal
Clinical narrative: Approximately 8 hours after vaccination reports ipsilateral tinnitus and burning sensation in left arm and left food. Has occurred episodically over the last 4 weeks. Also notes new onset fatigue, malaise, decreased appetite. Trial of prednisone with no improvement. Unclear if vaccination is related.
Age: 73.0
Sex: M
Vaccine: FLU4
Symptoms: Computerised tomogram, Musculoskeletal pain, X-ray
Clinical narrative: Pain in shoulder the following day of vaccine which has gotten progressively worse and now is almost intolerable.
Age: 56.0
Sex: M
Vaccine: VARZOS
Symptoms: Asthenia, Chills, Pain in extremity, Pyrexia
Clinical narrative: Pt. had the usual sore arm begin a few hours after the shot, but a 7pm started experiencing extreme chills followed by a very high fever he guessed to be about 103-104, but he was so debilitated he could not get out of bed to get a thermometer to read it. He said it broke about 3 am. He started to feel a little better after that and was continuing to feel better as time passed.
Age: 76.0
Sex: M
Vaccine: FLU3
Symptoms: Extra dose administered
Clinical narrative: Patient was given a flu vaccine on 12/3/18 by this nurse, when this nurse was charting the vaccine in our EMR, it was noted that the patient had previously been given a flu vaccine on 10/25/2018 in a different providers office.
Age: 22.0
Sex: F
Vaccine: FLU4, PPV
Symptoms: Body temperature increased, Injection site swelling
Clinical narrative: Swelling to left deltoid and elevated temp. Went to ER.
Age: 59.0
Sex: M
Vaccine: VARZOS
Symptoms: Chills, Fatigue, Injection site pain, Nausea, Pain
Clinical narrative: 3 Days of pain at injection site, fatigue, body ache, off and on fever, some shivers occasionally, intermittent nausea.
Age: 59.0
Sex: M
Vaccine: VARZOS
Symptoms: Pyrexia
Clinical narrative: 3 Days of pain at injection site, fatigue, body ache, off and on fever, some shivers occasionally, intermittent nausea.
Age: 65.0
Sex: M
Vaccine: UNK
Symptoms: Erythema, Pruritus, Urticaria
Clinical narrative: Red, raised, itchy welts (hives) on pt's abdomen, neck, arms and legs. Recommended BENADRYL.
Age: 66.0
Sex: F
Vaccine: PNC13
Symptoms: Mobility decreased
Clinical narrative: Was unable to lift or move arm for a one month period from date of injection.
Age: 12.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site pain
Clinical narrative: Patient complaining of prolonged right arm pain at the site where vaccine was administered. Pain has continued to occur since 11/8/18, so now has been occurring for over three weeks. Treatment includes: icing area 3-4 times per day, ibuprofen as needed.
Age: 61.0
Sex: M
Vaccine: FLU4
Symptoms: Pain, Pain in extremity
Clinical narrative: The patient is experiencing pain when he lift his arm, went to emergency room on 12/02/2018 and the doctor prescribed meloxicam tablet. He did not start the medication yet.
Age: 7.0
Sex: F
Vaccine: FLU4
Symptoms: Syncope
Clinical narrative: Pt was very nervous about getting a flu shot. She was sitting in the chair being comforted by her dad. I gave her the flu shot and she fainted for about 5 seconds.
Age: 51.0
Sex: M
Vaccine: VARZOS
Symptoms: Asthenia, Chills, Injection site pain, Myalgia, Nausea
Clinical narrative: Within 18 hours of the shot: whole-body muscle pain, weakness, nausea, chills, very sore at the injection site. All symptoms faded within 36 hours of the shot.
Age: 4.0
Sex: F
Vaccine: FLU4
Symptoms: Blood test, Dyskinesia, Endoscopy gastrointestinal, Laboratory test, Rhinorrhoea
Clinical narrative: Child's parents noticed the child develop sudden tics a couple days after the shot was administered. Started with repeated sniffling then moved to full body convulsions and various other uncontrollable sounds and body movements or convulsions. These symptoms are ongoing and continue to be a challenge on a daily (minute by minute basis. Incredibly shocking and disturbing and worrisome.
Age: 4.0
Sex: F
Vaccine: FLU4
Symptoms: Seizure, Tic, Urine analysis
Clinical narrative: Child's parents noticed the child develop sudden tics a couple days after the shot was administered. Started with repeated sniffling then moved to full body convulsions and various other uncontrollable sounds and body movements or convulsions. These symptoms are ongoing and continue to be a challenge on a daily (minute by minute basis. Incredibly shocking and disturbing and worrisome.
Age: 2.0
Sex: F
Vaccine: HEPA
Symptoms: Pruritus, Urticaria
Clinical narrative: HIVES DEVELOPED ON LEFT LEG AND THEN RIGHT LEG. THEN DEVELOPED ON BOTH ARMS. CHILD HAD ITCHING. SHE WAS SCRATCHING A LOT. MOM CALLED NURSE HOTLINE @ HOSPITAL.
Age: 55.0
Sex: F
Vaccine: FLU4, VARZOS
Symptoms: Dizziness, Fatigue, Feeling cold, Loss of control of legs, Vomiting
Clinical narrative: Severe chills, vomiting, dizziness, lost control of my legs while walking and collapsed, did not lose consciousness, tiredness. Lasted for 3 days.
Age: 13.0
Sex: M
Vaccine: HEPA
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: No adverse event but vaccine error (the pediatric pt received a vaccine that is for adult use only)
Age: 16.0
Sex: M
Vaccine: HEPA
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: No adverse event but vaccine error (pediatric pt got vaccine for adult use only).
Age: 53.0
Sex: F
Vaccine: FLU4
Symptoms: Injected limb mobility decreased, Muscular weakness, Pain in extremity, Sleep disorder
Clinical narrative: Almost 2 months later my left arm still hurt and I have limited motion. If I get it raised, it's painful and more painful to lower it. I have weaknesses and difficulty doing everyday task. I have trouble sleeping due to the pain.
Age: 15.0
Sex: F
Vaccine: HEPA
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: No adverse event but vaccine error (pediatic patient received vaccie for adult use only).
Age: 18.0
Sex: M
Vaccine: FLU4, HEP, HEPA, HPV9, IPV, MMR, MNQ, TDAP, VARCEL
Symptoms: Loss of consciousness, Pallor, Tremor
Clinical narrative: PT RECEIVED SEVERAL VACCINES TODAY, QUICKLY BECAME PALE ASKED FOR WATER AND GIVEN, TOOK A FEW SIPS THEN LOST CONSCIOUSNESS AND BODY SHOOK AND SEMI SLID DOWN ON THE CHAIR X 30 SECONDS, REGAINED CONSCIOUSNESS SAT UP IN CHAIR AND B/P TAKEN, PTS KNEES WERE ELEVATED AND DR CHECKED PTS HEARTBEAT, PT STATES HE DID NOT EAT TODAY, PT TOOK IN SMALL AMT OF WATER AND GIVEN SPRITE AND A SMALL AMT OF CEREAL, AND SAT IN CLINIC UNTIL HE FELT BETTER, PT LEFT AMBULATORY HOME WITH HIS FEMALE COMPANION WHO WAS DRIVING FOR HIM.